Sign In
Buy EBS
$7.93
-0.280 (-3.41%)
At Close: Jun 03, 2026
Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
07:59am, Wednesday, 07'th Jan 2026
GAITHERSBURG, Md., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that Joe Papa, president and chief executive officer, will provide a company presentation du
Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site
08:30am, Friday, 12'th Dec 2025
GAITHERSBURG, Md., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental Biologics License
GAITHERSBURG, Md., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) recognizes the 10-year anniversary of the U.S. Food and Drug Administration (FDA) approval of NARCAN® (nal
Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors
04:01pm, Wednesday, 12'th Nov 2025
GAITHERSBURG, Md., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) announced today that Dr. Louis W.
Blueone Card Inc. Subsidiary Millennium EBS Partners with DFCC Bank in Sri Lanka to Implement ISO Transformer Solution
02:00pm, Tuesday, 11'th Nov 2025
Los Angeles, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Blueone Card Inc. (OTCQX:BCRD) is pleased to announce that its wholly owned subsidiary, Millennium EBS Inc., has entered into an agreement with DFCC B
Looking for a Fast-paced Momentum Stock at a Bargain? Consider Emergent Biosolutions (EBS)
09:56am, Friday, 07'th Nov 2025
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Emergent Biosolutions (EBS) could be a great choice. It is one of the several stocks
Emergent BioSolutions: Solid Q3, Expecting Better Days To Come
11:00pm, Thursday, 06'th Nov 2025
Emergent BioSolutions maintains a Buy rating, supported by recent Q3 earnings beat and CEO Joe Papa's turnaround progress. EBS reported Q3 revenues of $231.1M and net income of $51.2M, surpassing guid
Emergent Biosolutions Inc. (EBS) Soars to 52-Week High, Time to Cash Out?
11:38am, Friday, 31'st Oct 2025
Emergent Biosolutions (EBS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Emergent BioSolutions Inc. (EBS) Q3 2025 Earnings Call Transcript
08:56pm, Wednesday, 29'th Oct 2025
Emergent BioSolutions Inc. ( EBS ) Q3 2025 Earnings Call October 29, 2025 5:00 PM EDT Company Participants Frank Vargo Joseph Papa - CEO, President & Director Richard Lindahl - Executive VP, CFO & Tre
Emergent Biosolutions (EBS) Beats Q3 Earnings and Revenue Estimates
07:06pm, Wednesday, 29'th Oct 2025
Emergent Biosolutions (EBS) came out with quarterly earnings of $1.06 per share, beating the Zacks Consensus Estimate of a loss of $0.12 per share. This compares to earnings of $1.37 per share a year
Emergent BioSolutions Reports Third Quarter 2025 Financial Results
04:15pm, Wednesday, 29'th Oct 2025
Third Quarter 2025 Total Revenues of $231.1 million, above the high end of Q3 guidance by $21.0 million Third Quarter 2025 Net Income of $51.2 million and Net Income Margin of 22% Third Quarter 2025 G
Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness
08:00am, Tuesday, 28'th Oct 2025
GAITHERSBURG, Md., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the results of a new survey1 of approximately 250 U.S. policy opinion leaders showing that n
Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025
07:45am, Wednesday, 08'th Oct 2025
GAITHERSBURG, Md., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, October 29, 2025, at 5:00 pm eastern time to discuss the financial
Millennium EBS Secures Agreement and Purchase Order from Global IME Bank for ISO 20022 Transformer Solution
03:22pm, Wednesday, 01'st Oct 2025
LOS ANGELES, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Millennium EBS, a subsidiary of Blueone Card Inc. (OTCQX: BCRD), today announced that it has signed an agreement and received a purchase order from Globa
3 Small-Cap Stocks to Watch After the Fed's Rate Cuts
09:57am, Monday, 29'th Sep 2025
The Russell 2000 index (i.e., the small-cap stock index) is up about 2.5% in the five days ending September 19.
